EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,740 | -24.1% | 3,300 | -19.9% | 0.01% | -23.5% |
| Q2 2023 | $33,916 | +13.5% | 4,121 | 0.0% | 0.02% | +6.2% |
| Q1 2023 | $29,877 | -40.0% | 4,121 | -26.6% | 0.02% | -44.8% |
| Q4 2022 | $49,778 | -29.9% | 5,612 | -2.9% | 0.03% | -31.0% |
| Q3 2022 | $71,000 | +1675.0% | 5,782 | +1753.2% | 0.04% | +2000.0% |
| Q2 2022 | $4,000 | -33.3% | 312 | -6.9% | 0.00% | -33.3% |
| Q1 2022 | $6,000 | -57.1% | 335 | -35.6% | 0.00% | -57.1% |
| Q4 2021 | $14,000 | -6.7% | 520 | +44.4% | 0.01% | -22.2% |
| Q3 2021 | $15,000 | -90.5% | 360 | -87.1% | 0.01% | -90.7% |
| Q2 2021 | $158,000 | +378.8% | 2,785 | +258.0% | 0.10% | +304.2% |
| Q1 2021 | $33,000 | -51.5% | 778 | -19.2% | 0.02% | -57.1% |
| Q4 2020 | $68,000 | +277.8% | 963 | +51.4% | 0.06% | +211.1% |
| Q3 2020 | $18,000 | – | 636 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |